Acute respiratory distress syndrome;Syndrome de détresse respiratoire aiguë

EMC - Pneumologie

Volumn 1, Issue 4, 2004, Pages 143-186

  Chevrolet, J C ^a   Tassaux, D ^a   Jolliet, P ^a   Pugin, J ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Acute respiratory distress syndrome; ARDS; Mechanical ventilation

Indexed keywords

EID: 33645719215     PISSN: 17624223     EISSN: 17624223     Source Type: Journal    
DOI: 10.1016/j.emcpn.2004.08.001     Document Type: Short Survey

References (136)

1. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet 1967;2:233-9.
2. Bernard GR, Artigas A, Brigham KL, Cartel J, Falke K, Hudson L, et al. The American-European consensus conference on ARDS. Am J Respir Crit Care Med 1994;149:818-24.
3. Gattinoni L, Pelosi P, Suter PM, Pedoto A, Vercesi P, Lissoni A. Acute respiratory distress syndrome caused by pulmonary and extrapulmonary disease: different syndromes? Am J Respir Cell Mol Biol 1998;158:3-11.
4. Herridge MS, Cheung AM, Tansey CM, Matte-Martyn A, Diaz-Granados N, Al-Saidi F, et al. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 2003;348:683-93.
5. Ware L, Matthay R. The acute respiratory distress syndrome. N Engl J Med 2000;342:1334-49.
6. Vincent J, Sakr Y, Ranieri V. Epidemiology and outcome of acute respiratory failure in intensive care unit patients. Crit Care Med 2003;31(suppl):S296-S299.
7. Goss CH, Brower RG, Hudson LD, Rubenfeld GD, ARDS Network. Incidence of acute lung injury in the United States. Crit Care Med 2003;31:1607-11.
8. Roupie E, Lepage E, Wysocki M. Prevalence, etiologies and outcome of the acute respiratory distress syndrome among hypoxemic ventilated patients. Intensive Care Med 1999;25:920-9.
9. Hudson LD, Milberg JA, Anardi D, Maunder RJ. Clinical risk factors for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1995;151:293-301.
10. Krafft P, Fridrich P, Pernerstorfer T, Fitzgerald RD, Koc D, Schneider B, et al. The acute respiratory distress syndrome: definitions, severity and clinical outcome. An analysis of 101 clinical investigations. Intensive Care Med 1996;22:519-29.
11. Sloane PJ, Gee MH, Gottlieb JE, Albertine KH, Peters SP, Burns JR, et al. A multicenter registry of patients with acute respiratory failure. Physiology and outcome. Am Rev Respir Dis 1992;146:419-26.
12. Montgomery AB, Stager MA, Carrico CJ, Hudson LD. Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1985;132:485-9.
13. Meduri GU, Headley S, Kohler G, Stentz F, Tolley E, Umberger R, et al. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Chest 1995;107:1062-73.
14. Meduri GU, Kohler G, Headley S, Tolley E, Stentz F, Postlethwaite A. Inflammatory cytokines in the BAL of patients with ARDS. Chest 1995;108:1303-14.
15. nd F, Park DR, et al. Cytokine balance in the lungs of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 2001;164:1896-903.
16. Munford R, Pugin J. Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am J Respir Crit Care Med 2001;163:316-21.
17. Goodman RB, Pugin J, Lee JS, Matthay MA. Cytokine-mediated inflammation in acute lung injury. Cytokine Growth Factor Rev 2003;14:523-35.
18. Abel SJ, Finney SJ, Brett SJ, Keogh BF, Morgan CJ, Evans TW. Reduced mortality in association with the acute respiratory distress syndrome (ARDS). Thorax 1998;53:292-4.
19. Orme Jr J, Romney JS, Hopkins RO, Pope D, Chan KJ, Thomsen G, et al. Pulmonary function and health-related quality of life in survivors of acute respiratory distress syndrome. Am J Respir Crit Care Med 2003;167:690-4.
20. De Jonghe B, Sharshar T, Lefaucheur JP, Authier FJ, Durand-Zaleski I, Boussarsar M, et al. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA 2002;288:2859-67.
21. Idell S. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury. Crit Care Med 2003;31(suppl):S213-S220.
22. Martin T, Nakamura M, Matute-Bello G. The role of apoptosis in acute lung injury. Crit Care Med 2003;31(suppl):S184-S188.
23. Luca R, Lijnen HR, Suffredini AF, Pepper MS, Steinberg KP, Martin TR, et al. Increased angiostatin levels in bronchoalveolar lavage fluids from ARDS patients and from human volunteers after lung instillation of endotoxin. Thromb Haemost 2002;87:966-71.
24. Munford RS, Pugin J. The crucial role of systemic responses in the innate (non-adaptive) host defense. J Endotoxin Res 2001;7:327-32.
25. Fumeaux T, Pugin J. Role of interleukin-10 in the intracellular sequestration of human leukocyte antigen-DR in monocytes during septic shock. Am J Respir Crit Care Med 2002;166:1475-82.
26. Wollenberg GK, LaMarre J, Rosendal S, Gonias SL, Hayes MA. Binding of tumor necrosis factor alpha to activated forms of human plasma alpha-2 macroglobulin. Am J Pathol 1991;138:265-72.
27. Kurdowska AK, Geiser TK, Alden SM, Dziadek BR, Noble JM, Nuckton TJ, et al. Activity of pulmonary edema fluid interleukin-8 bound to alpha(2)-macroglobulin in patients with acute lung injury. Am J Physiol Lung Cell Mol Physiol 2002;282:1092-8.
28. Thickett DR, Armstrong L, Christie SJ, Millar AB. Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome. Am J Respir Crit Care Med 2001;164:1601-5.
29. Abraham E. Neutrophils and acute lung injury. Crit Care Med 2003;31(suppl):S195-S199.
30. Goodman RB, Strieter RM, Martin DP, Steinberg KP, Milberg JA, Maunder RJ, et al. Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1996;154:602-11.
31. Moraes T, Chow C, Downey G. Proteases and lung injury. Crit Care Med 2003;31(suppl):S189-S194.
32. Delclaux C, d'Ortho M, Delacourt C. Gelatinases in epithelial lining fluid of patients with the acute respiratory distress syndrome. Am J Physiol 2001;272:L442-L451.
33. Chow CW, Herrera Abreu MT, Suzuki T, Downey GP. Oxidative stress and lung injury. Am J Respir Cell Mol Biol 2003;29:427-31.
34. Chabot F, Mitchell JA, Gutteridge JM, Evans TW. Reactive oxygen species in acute lung injury. Eur Respir J 1998;11:745-57.
35. Kharitonov SA, Barnes PJ. Exhaled markers of pulmonary diseases. Am J Respir Crit Care Med 2001;163:1693-722.
36. Gutteridge JM, Quinlan GJ, Mumby S, Heath A, Evans TW. Primary plasma antioxidants in adult respiratory distress syndrome patients: changes in iron-oxidizing, iron-binding, and free radical-scavenging proteins. J Lab Clin Med 1994;124:263-73.
37. Messent M, Inclair D, Quinlan G. Pulmonary vascular permeability after cardio-pulmonary bypass and its relation ship to oxidative stress. Crit Care Med 1997;25:425-9.
38. Maines MD. Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical implications. FASEB J 1988;2:2557-68.
39. Quinlan G, Evans T, Gutteridge J. Iron and the redox status of the lungs. Free Radic Biol Med 2002;33:1306-13.
40. Otterbein L, Chapman J. Carbon monoxide (A gaseous molecule with anti-inflammatory properties), Disease markers in exhaled breath. New York: Marcel Dekker; 2003. p. 133-56.
41. Wernermann J, Luo J, Hammarqvist F. Glutathione status in critically ill patients: possibility of modulation by antioxydants. Proc Nutr Soc 1999;58:677-80.
42. Bernard GR, Wheeler AP, Arons MM, Morris PE, Paz HL, Russell JA, et al. A trial of antioxidants N-acetylcysteine and procysteine in ARDS (The Antioxidant in ARDS Study Group), Chest 1997;112:164-72.
43. Idell S. Extravascular coagulation and fibrin deposition in acute lung injury. New Horiz 1994;2:566-74.
44. Abraham E. Coagulation abnormalities in acute lung injury and sepsis. Am J Respir Cell Mol Biol 2000;22:401-4.
45. Idell S, James K, Levin E. Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. J Clin Invest 1989;84:695-705.
46. Barazzone C, Belin D, Piguet PF, Vassalli JD, Sappino AP. Plasminogen activator inhibitor-1 in acute hyperoxic mouse lung injury. J Clin Invest 1996;98:2666-73.
47. Pugin J. Ventilator-induced lung injury: an inflammatory disease? Clin Pulm Med 1998;23:290-9.
48. Pugin J. Molecular mechanisms of lung cell activation induced by cyclic stretch. Crit Care Med 2003;31(suppl):S200-S206.
49. Pugin J, Dunn I, Jolliet P, Tassaux D, Magnenat JL, Nicod LP, et al. Mechanical ventilation induces the secretion of inflammatory mediators by human macrophages in vitro. Am J Physiol 1998;275:L1040-L1050.
50. Welsh DA, Summer WR, Dobard EP, Nelson S, Mason CM. Keratinocyte growth factor prevents ventilator-induced lung injury in an ex vivo rat model. Am J Respir Crit Care Med 2000;62:1081-6.
51. Imai Y, Parodo J, Kajikawa O, de Perrot M, Fischer S, Edwards V, et al. Injurious mechanical ventilation and end-organ epithelial cell apoptosis and organ dysfunction in an experimental model of acute respiratory distress syndrome. JAMA 2003;289:2104-12.
52. Amato M. Improved lung mechanics and oxygenation achieved through a new approach to mechanical ventilation in ARDS. Am Rev Respir Dis 1993;147:A890 [abstract].
53. Dreyfuss D, Ricard JD, Saumon G. On the physiologic and clinical relevance of lung-borne cytokines during ventilator-induced lung injury. Am J Respir Crit Care Med 2003;167:1467-71.
54. Hynes R. Integrins: versatility, modulation, and signalling in cell adhesion. Br J Pharmacol 1999;126:537-50.
55. Burke-Gaffney A, Griffiths M. Adhesion molecules in acute lung injury. In: Evans T, Griffiths M, Keogh B, editors, Acute respiratory distress syndrome. Sheffield: European Respiratory Society Monographs; 2002. p. 83-104.
56. Villar J, Flores C, Mendez-Alvarez S. Genetic susceptibility to acute lung injury. Crit Care Med 2003;31(suppl):S272-S275.
57. Pugin J, Heumann ID, Tomasz A, Kravchenko VV, Akamatsu Y, Nishijima M, et al. CD14 is a pattern recognition receptor. Immunity 1994;1:509-16.
58. Lewis J, Jobe A. Surfactant and the adult respiratory syndrome. Am Rev Respir Dis 1993;147:218-33.
59. Gunther A, Siebert C, Schmidt R, Ziegler S, Grimminger F, Yabut M, et al. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung oedema. Am J Respir Crit Care Med 1996;153:176-84.
60. Günther D. Surfactant metabolism and replacement in acute respiratory distress syndrome. In: Evans T, Griffiths M, Keogh B, editors, Acute respiratory distress syndrome. Sheffield: European Respiratory Society Monographs; 2002. p. 119-28.
61. Burckhardt A. Alveolitis and collapse in the pathogenesis of pulmonary fibrosis. Am Rev Respir Dis 1989;140:513-24.
62. Chrousos G. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995;332:1351-62.
63. Maes M, Song C, Lin A, De Jongh R, Van Gastel A, Kenis G, et al. The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and Th-1-like response in stress-induced anxiety. Cytokine 1998;10:313-8.
64. Pugin J, Verghese G, Widmer MC, Matthay MA. The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome. Crit Care Med 1999;27:304-12.
65. Dugernier TL, Laterre PF, Wittebole X, Roeseler J, Latinne D, Reynaert MS, et al. Compartmentalization of the inflammatory response during acute pancreatitis: correlation with local and systemic complications. Am J Respir Crit Care Med 2003;168:148-57.
66. Ranieri VM, Giunta F, Suter PM, Slutsky AS. Mechanical ventilation as a mediator of multisystem organ failure in patients with acute respiratory distress syndrome. JAMA 2000;284:43-4.
67. Brenner C, Kroemer G. Apoptosis (Mitochondria: the death signal integrators), Science 2000;289:1150-1.
68. Haslett C. Granulocyte apoptosis and its role in the resolution and control of lung inflammation. Am J Respir Crit Care Med 1999;160:55-511.
69. Martin C, Papazian L, Payan MJ, Saux P, Gouin F. Pulmonary fibrosis correlates with outcome in adult respiratory distress syndrome. A study in mechanically ventilated patients. Chest 1995;107:196-200.
70. Madtes DK, Rubenfeld G, Klima LD, Milberg JA, Steinberg KP, Martin TR, et al. Elevated transforming growth factor-alpha levels in bronchoalveolar lavage fluid of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1998;158:424-30.
71. Geiser T, Atabai K, Jarreau PH, Ware LB, Pugin J, Matthay MA. Pulmonary oedema fluid from patients with acute injury augment alveolar epithelial repair by an interleukin-1β dependent mechanism. Am J Respir Crit Care Med 2001;163:1384-8.
72. Verghese GM, McCormick-Shannon K, Mason RJ, Matthay MA. Hepatocyte growth factor and keratinocyte growth factor in the pulmonary edema fluid of patients with acute lung injury. Am J Respir Crit Care Med 1998;158:386-94.
73. Bellingan G. Resolution of inflammation and repair. In: Evans T, Griffiths M, Keogh B, editors, Acute respiratory distress syndrome. Sheffield: European Respiratory Society Monographs; 2002. p. 70-82.
74. Sartori C, Matthay M. Alveolar epithelial fluid transport. In: Evans T, Griffiths M, Keogh B, editors, Acute respiratory distress syndrome. Sheffield: European Respiratory Society Monographs; 2002. p. 47-9.
75. Matthay M. Alveolar fluid clearance in patients with ARDS: does it make a difference ? Chest 2002;122:3405-3435.
76. Pesenti A, Pelosi P, Gattinoni L. Lung mechanics in ARDS. In: Vincent J editor, Update in intensive care and emergency medicine. Berlin: Springer-Verlag; 1990. p. 231-8.
77. Matamis D, Lemaire F, Harf A, Brun-Buisson C, Ansquer JC, Atlan G. Total respiratory pressure-volume curves in the adult respiratory distress syndrome. Chest 1984;86:58-66.
78. Gattinoni L, Pesenti A, Avalli L, Rossi F, Bombino M. Pressure-volume curve of total respiratory system in acute respiratory failure. Computed tomographic scan study. Am Rev Respir Dis 1987;136:730-6.
79. Gattinoni L, Pesenti A, Bombino M, Baglioni S, Rivolta M, Rossi F, et al. Relationships between lung computed tomographic density, gas exchange, and PEEP in acute respiratory failure. Anesthesiology 1988;69:824-32.
80. Dantzker DR, Brook CJ, Dehart P, Lynch JP, Weg JG. Ventilation-perfusion distributions in the adult respiratory distress syndrome. Am Rev Respir Dis 1979;120:1039-52.
81. Lamy M, Fallat RJ, Koeniger E, Dietrich HP, Ratliff JL, Eberhart RC, et al. Pathologic features and mechanisms of hypoxemia in ARDS. Am Rev Respir Dis 1976;114:267-84.
82. Gutierrez G. Cellular energy metabolism during hypoxia. Crit Care Med 1991;19:619-26.
83. Dantzker D, Foresman B, Gutierrez G. Oxygen supply and utilization relationships. A reevaluation. Am Rev Respir Dis 1991;143:675-9.
84. Shibutani K, Komatsu T, Kubal K, Sanchala V, Kumar V, Bizzarri DV. Critical level of oxygen delivery in anesthetized man. Crit Care Med 1983;11:640-3.
85. Danek SJ, Lynch JP, Weg JG, Dantzker DR. The dependence of oxygen uptake on oxygen delivery in the adult respiratory distress syndrome. Am Rev Respir Dis 1980;122:387-95.
86. Tomashefski J. Pulmonary pathology of the adult respiratory distress syndrome. Clin Chest Med 1990;11:593-619.
87. Meduri GU, Belenchia JM, Estes RJ, Wunderink RG, el Torky M, Leeper Jr KV. Fibroproliferative phase of Ards (Clinical findings and effects of corticosteroids), Chest 1991;100:943-52.
88. Tomashefski Jr JF, Davies P, Boggis C, Greene R, Zapol WM, Reid LM. The pulmonary vascular lesions of the adult respiratory distress syndrome. Am J Pathol 1983;112:112-26.
89. Aberle D, Brown K. Radiologic considerations in the adult respiratory distress syndrome. Clin Chest Med 1990;11:737-54.
90. Gattinoni L, Pelosi P, Pesenti A, Brazzi L, Vitale G, Moretto A, et al. CT scan in ARDS: clinical and physiopathological insights. Acta Anaesthesiol Scand [suppl] 1991;95:87-96.
91. Goodman LR, Fumagalli R, Tagliabue P, Tagliabue M, Ferrario M, Gattinoni L, et al. Adult respiratory distress syndrome due to pulmonary and extrapulmonary causes: CT, clinical and functional correlation. Radiology 1999;213:545-52.
92. Gattinoni L, Vagginelli F, Chiumello D, Taccone P, Carlesso E. Physiologic rationale for ventilator setting in acute lung injury/acute respiratory distress syndrome. Crit Care Med 2003;31(suppl4):S300-S304.
93. Sackett DL. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 1986;89(suppl2):2S-3S.
94. Valente-Barbas CS. Lung recruitment manoeuvers in acute respiratory distress syndrome and facilitating resolution. Crit Care Med 2003;31(suppl4):S265-S271.
95. Brower RG, Ware LB, Berthiaume Y, Matthay MA. Treatment of acute respiratory distress syndrome. Chest 2001;120:1347-67.
96. Sassoon S. Ventilator-associated diaphragmatic dysfunction. Am J Respir Crit Care Med 2002;166:1135-40.
97. Ardsnet. Acute respiratory distress syndrome network - Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000;342:1301-8.
98. Amato MB, Barbas CS, Medeiros DM, Schettino Gde P, Lorenzi Filho G, Kairalla RA, et al. Beneficial effects of the open lung approach with low distending pressures in acute respiratory distress syndrome. Am J Respir Crit Care Med 1995;152:1835-46.
99. Feihl F, Perret C. Permissive hypercapnia (How permissive should we be?), Am J Respir Crit Care Med 1994;150:1722-37.
100. Muscedere JG, Mullen JB, Can K, Slutsky AS. Tidal ventilation at low airway pressures can cause pulmonary barotrauma. Am J Respir Crit Care Med 1994;149:1327-34.
101. Hickling K. Lung-protective ventilation in acute respiratory distress syndrome. Protection by reduced lung stress or by therapeutic hypercapnia? Am J Respir Crit Care Med 2000;162:2021-2.
102. Ranieri VM, Zhang H, Mascia L, Aubin M, Lin CY, Mullen JB, et al. Pressure-time curve predicts minimally injurious ventilatory in an isolated rat lung model. Anesthesiology 2000;93:1320-8.
103. Delafosse C, Chevrolet JC, Suter P, Cox JN. Necrotizing tracheobronchitis: a complication of high-frequency jet ventilation. Virchows Arch A Pathol Anat 1988;413:257-64.
104. Ribeiro S, Tremblay L, Slutsky AS. High-frequency ventilation - principles and practice. In: Marini J, Slutsky AS, editors, Physiologic basis of ventilatory support. New York: Marcel Dekker; 1998. p. 889-920.
105. Ward N. Effects of prone position in ARDS. An evidence-based review of the literature. Crit Care Clin 2002;18:35-45.
106. Pelosi P, Tubiolo D, Mascheroni D, Vicardi P, Crotti S, Valenza F, et al. Effects of the prone position on respiratory mechanics and gas exchange during acute lung injury. Am J Respir Crit Care Med 1998; 157:387-93.
107. Gattinoni L, Tognoni G, Pesenti A, Taccone P, Mascheroni D, Labarta V, et al. Effects of prone positioning on the survival of patients with acute respiratory failure. N Engl J Med 2001;345:568-73.
108. 2 with prone position is predictive of improved outcome in acute respiratory distress syndrome. Crit Care Med 2003;31:2727-33.
109. Lapinsky SE, Aubin M, Mehta S, Boiteau P, Slutsky AS. Safety and efficacy of sustained inflation for alveolar recruitment in adults with respiratory failure. Intensive Care Med 1999;25:1297-301.
110. Pelosi P, Bottino N, Chiumello D, Caironi P, Panigada M, Gamberoni C, et al. Sigh in supine and prone position during acute respiratory distress syndrome. Am J Respir Crit Care Med 2003;167:521-7.
111. Girou E, Schortgen F, Delclaux C, Brun-Buisson C, Blot F, Lefort Y, et al. Association of noninvasive ventilation with nosocomial infections and survival in critically ill patients. JAMA 2000;284:2361-7.
112. 2 removal in acute respiratory failure. JAMA 1986;256:881-9.
113. 2 removal. Am J Respir Crit Care Med 1994;149:295-305.
114. Hattler BG, Lund LW, Golob J, Russian H, Lann MF, Merrill TL, et al. A respiratory gas exchange catheter - in vitro and in vivo tests in large animals. J Thorac Cardiovasc Surg 2002;124:520-30.
115. Humphrey H, Hall J, Sznajder I, Silverstein M, Wood L. Improved survival in ARDS patients associated with a reduction in pulmonary capillary wedge pressure. Chest 1990;97:1176-80.
116. Dantzker D, Lynch J, Weg J. Depression of cardiac output is a mechanism of shunt reduction in the therapy of acute respiratory failure. Chest 1980;77:636-42.
117. Shoemaker WC, Appel PL, Kram HB, Waxman K, Lee TS. Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. Chest 1988;94:1176-86.
118. Russell JA, Phang PT. The oxygen delivery/consumption controversy (Approaches to the management of the critically ill), Am J Respir Crit Care Med 1994;149:533-7.
119. Eidelman L, Pizov R, Sprung C. New therapeutic approaches in sepsis: a critical review. Intensive Care Med 1995;21:5269-5272.
120. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, et al. The recombinant human activated protein C worldwide evaluation in severe sepsis (PROWESS) study group (Efficacy and safety of recombinant human activated protein-C for severe sepsis), N Engl J Med 2001;344:699-709.
121. Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002;288:862-71.
122. Loriaux L. Glucocorticoid therapy in the intensive care unit. N Engl J Med 2004;350:1601-2.
123. Meduri GU, Headley AS, Golden E, Carson SJ, Umberger RA, Kelso T, et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome - a randomized controlled trial. JAMA 1998;280:182-3.
124. Meduri GU, Tolley EA, Chrousos GP, Stentz F. Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome. Am J Respir Crit Care Med 2002;165:983-91.
125. Cranshaw J, Evans RM. Prospects for pharmacotherapy in acute respiratory distress syndrome. In: Evans T, Griffiths M, Keogh B, editors, Acute respiratory distress syndrome. Sheffield: European Respiratory Society Monographs; 2002. p. 247-65.
126. Spragg RG, Lewis JF, Wurst W, Hafner D, Baughman RP, Wewers MD, et al. Treatment of acute respiratory distress syndrome with recombinant protein C surfactant. Am J Respir Crit Care Med 2003;167:1562-6.
127. Rossaint R, Gerlach H, Schmidt-Ruhnke H, Pappert D, Lewandowski K, Steudel W, et al. Efficacy of inhaled nitric oxide in patients with ARDS. Chest 1995;107:1107-15.
128. Puybasset L, Rouby J. Inhaled nitric oxide in acute respiratory failure. In: Vincent J editor, Yearbook of intensive care and emergency medicine. Berlin: Springer-Verlag; 1995. p. 331-57.
129. Payen D, Vallet B. Results of the French multicentric randomized double-blind placebo-controlled trial on nitric oxide in ARDS. Intensive Care Med 1999;25:S166.
130. Plaisance P, Payen D. Role of almitrine-induced pulmonary arterial pressure increase on gas exchange improvement. Intensive Care Med 1992;18:S111.
131. Jolliet P, Bulpa P, Ritz M, Ricou B, Lopez J, Chevrolet JC. Additive beneficial effects of the prone position, nitric oxide, and almitrine bismesylate on gas exchange and oxygen transport in the acute respiratory distress syndrome (ARDS). Crit Care Med 1997;25:786-94.
132. Hirschl RB, Croce M, Gore D, Wiedemann H, Davis K, Zwischenberger J, et al. The Adult partial Liquid Ventilation Study Group - Prospective, randomized, controlled pilot study of partial liquid ventilation in adult acute respiratory distress syndrome. Am J Respir Crit Care Med 2002;165:781-7.
133. Cole L, Bellomo R, Journois D, Davenport P, Baldwin I, Tipping P. High-volume haemofiltration in human septic shock. Intensive Care Med 2001;27:978-86.
134. Beale R, Bryg D, Bihari D. Immunonutrition in the critically ill: a systematic review of clinical outcome. Crit Care Med 1999;27:2799-805.
135. Eggimann P, Harbarth S, Constantin MN, Touveneau S, Chevrolet JC, Pittet D. Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care. Lancet 2000;355:1864-8.
136. Eggimann P, Harbarth S, Ricou B, Hugonnet S, Fernere K, Suter P, et al. Acute respiratory distress syndrome after bacteremic sepsis does not increase mortality. Am J Respir Crit Care Med 2003;167:1210-4.